• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.52% Nasdaq Down 0.25%

    Alder Biopharmaceuticals Inc. (ALDR)

    -NasdaqGM
    45.12 Down 1.30(2.80%) Aug 3, 4:00PM EDT
    Add to Portfolio
    Prev Close:46.42
    Open:46.26
    Bid:44.33 x 100
    Ask:59.42 x 400
    1y Target Est:52.00
    Beta:N/A
    Next Earnings Date: 5-Aug-15ALDR Earnings announcement
    Day's Range:44.51 - 47.90
    52wk Range:10.52 - 54.90
    Volume:412,156
    Avg Vol (3m):901,512
    Market Cap:1.91B
    P/E (ttm):N/A
    EPS (ttm):-0.02
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ALDR

    Comparison

    Symbol% ChgMkt Cap
    ALDRDown 2.80%1.91B
    ABBVDown 0.40%111.09B
    JNJDown 0.19%277.36B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):35.29
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.64
    Quarterly EPS Est (Jun-15) :-0.40
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):-1.20

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alder BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes various therapeutic antibodies in the United States and Australia. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback